Zobrazeno 1 - 10
of 94
pro vyhledávání: '"John G Walt"'
Publikováno v:
Clinical Ophthalmology, Vol 2010, Iss default, Pp 1131-1135 (2010)
Alfred M Solish1,2, Friedericke James1, John G Walt3, Tina H Chiang31Southern California Glaucoma Consultants, Pasadena CA, USA; 2Jules Stein Eye Institute, University of California Los Angeles, Los Angeles, 3Allergan Inc., Irvine, CA, USA Objective:
Externí odkaz:
https://doaj.org/article/1ff0a8842a494bd29a99b3782e52a73b
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
J Michael Jumper,1 Pravin U Dugel,2,3 Sanford Chen,4 Kevin J Blinder,5 John G Walt6 On behalf of the ECHO Study Group 1West Coast Retina Medical Group, San Francisco, CA, USA; 2Retinal Consultants of Arizona, Phoenix, AZ, USA; 3USC Roski Eye Institut
Autor:
Kevin J. Blinder, David A Hollander, Sanford Chen, Lanita C Scott, J. Michael Jumper, John G. Walt, Pravin U. Dugel
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Kevin J Blinder,1 Pravin U Dugel,2,3 Sanford Chen,4 J Michael Jumper,5 John G Walt,6 David A Hollander,6 Lanita C Scott6 On behalf of the ECHO Study Group 1The Retina Institute, St Louis, MO, 2Retinal Consultants of Arizona, Phoenix, AZ, 3USC Roski E
Publikováno v:
Aesthetic Surgery Journal
Background Patient-reported outcome (PRO) measures have been used to assess treatment benefit in a variety of therapeutic areas and are now becoming increasingly important in aesthetic research. Objectives The objective of the current study was to de
Autor:
John G. Walt, Steven Fagien, Jean Carruthers, Sue Ellen Cox, Emily Weng, Frederick C. Beddingfield, David Wirta
Publikováno v:
Aesthetic Surgery Journal. 33:789-798
Background: Hypotrichosis of the eyelashes may negatively influence an individual's self-perception and appearance. Assessing the impact of treatment from a patient's perspective may be particularly relevant in trials of aesthetic agents. Once-daily
Publikováno v:
Journal of Glaucoma. 20:148-159
To evaluate the psychometric properties of the Glaucoma Symptom Identifier (GSI), a tool designed to assess multiple possible glaucoma symptoms and their impact on quality of life in clinical practice. We sought to address the need for better methods
Publikováno v:
Dermatologic Surgery. 36:638-649
Ocularly applied bimatoprost 0.03% is associated with increased eyelash growth.To assess the safety, efficacy, and subjective experience of using dermal application of bimatoprost 0.03% for the growth of natural eyelashes.Prospective, open-label stud
Publikováno v:
Journal of Managed Care Pharmacy. 15:728-740
BACKGROUND: The National Quality Forum recently endorsed the proportion of days covered (PDC)—a measure of medication adherence—as an indicator of quality in drug therapy management. OBJECTIVE: To inform initial efforts to improve the quality of
Publikováno v:
Drugs & Aging. 26:933-950
Chronic diseases have a long-term negative impact on quality of life (QOL). Decreased QOL is associated with increased financial burden on healthcare systems and society. However, few publications have investigated the impact of glaucoma on patients'
Publikováno v:
Journal of Glaucoma. 18:390-394
Purpose: To determine the relationship between mean deviation (MD) scores and resource utilization among glaucoma patients in the United States and Europe. Methods: A retrospective analysis of patient in the United States (June 1990 to January 2003,